Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 10/15/15  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Kathleen Dungan

Wrong Dr. Kathleen Dungan?

Division Associate Director of Cl...

Phone: (614) ***-****  HQ Phone
The Ohio State University
1971 Neil Ave. 210 Baker Systems
Columbus , Ohio 43210
United States

Company Description: The Ohio State University at Marion serves as one of five regional campuses to the Columbus main campus. As a regional campus, Marion offers the same excellent...   more

Employment History


  • OSU
  • MD
  • MPH
  • M.D.
17 Total References
Web References
\"The ease of access to this ..., 15 Oct 2015 [cached]
\"The ease of access to this evidence-based information ensures that the busy clinician understands today's advances in the care of people with diabetes,\" says Kathleen Dungan, MD, MPH, associate professor, associate division director for clinical services in the Division of Endocrinology of Diabetes and Metabolism at the Ohio State University and one of the program directors for eDiabetes Review.
Editorial Team - Endotext, 22 July 2015 [cached]
Kathleen Dungan
Kathleen Dungan
Associate Professor of Medicine at The Ohio State University Division of Endocrinology, Diabetes and Metabolism. Dr. Dungan attended medical school at OSU and completed her residency and fellowship in 2006 at University of North Carolina. She then returned to OSU where she serves as the division Associate Director of Clinical Services and the director of endocrine clinical trials, and oversees the inpatient diabetes program. She divides her time in clinical care and research in diabetes. Her research focuses on diabetes clinical trials, and ranges from quality improvement, pharmaceutical, and device interventions in the inpatient and outpatient settings. She has presented several times at national meetings such as the ADA and Endocrine Society and has published numerous manuscripts and chapters ranging from glucose monitoring, incretin based therapies, and insulins, to mechanistic and outcomes studies in hospitalized patients. She serves on the editorial board of Diabetes Technology & Therapeutics. She serves as the American Diabetes Association Central Ohio Community Leadership Board president and on the national ADA Scientific Sessions planning committee.
Kathleen Dungan
"Diabetes is a progressive disease that ..., 14 June 2014 [cached]
"Diabetes is a progressive disease that affects every patient differently," said Kathleen Dungan, MD, endocrinologist, associate professor, The Ohio State University Wexner Medical Center.
Dungan, K, Povedano, S, et al. Efficacy and Safety of Once Weekly Dulaglutide versus Once Daily Liraglutide in Type 2 Diabetes (AWARD-6). Abstract 110-LB. Presented at 74th American Diabetes Association (ADA) Scientific Sessions; June 13-17, 2014; San Francisco, CA. International Diabetes Federation. IDF Diabetes Atlas, 6th edn.Brussels, Belgium: International Diabetes Federation, 2013.
These findings were reported by ..., 7 June 2008 [cached]
These findings were reported by Kathleen Dungan, MD, of Ohio State University (Columbus, OH) and investigators from Eli Lilly (Indianapolis, IN) at the American Diabetes Association's 68th Annual Scientific Sessions (ADA) in San Francisco.
This is the largest clinical study to evaluate the clinical utility of GlycoMark to reflect after-meal glucose levels with 2,094 patients enrolled from 11 countries.The DURABLE trial (Assessing the Durability of Basal vs.Lispro Mix 75/25 Insulin Efficacy) confirms results from a smaller population study completed by John Buse, MD (University of North Carolina), Steven Wittlin, MD (University of Rochester), and Kathleen Dungan, MD, published in the medical journal Diabetes Care in June 2006.
Dr. Dungan concluded, "The data support the use of 1,5-anhydroglucitol, in conjunction with A1C, in moderately controlled patients with type 2 diabetes."
Kathleen Dungan, MD, ..., 17 May 2013 [cached]
Kathleen Dungan, MD, MPH The Ohio State University, Columbus, Ohio
Other People with the name "Dungan":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.